| scholarly article | Q13442814 |
| P2093 | author name string | Michael W Jakowec | |
| Ruth I Wood | |||
| Giselle M Petzinger | |||
| Eleni Antzoulatos | |||
| P2860 | cites work | The Impact of Gender and Estrogen on Striatal Dopaminergic Neurotoxicity | Q23912105 |
| Methamphetamine toxicity and messengers of death | Q24647617 | ||
| Altered striatal function in a mutant mouse lacking D1A dopamine receptors | Q28585357 | ||
| Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors | Q28587334 | ||
| Behavioral responses to cocaine and amphetamine administration in mice lacking the dopamine D1 receptor | Q28588599 | ||
| Memory, mood, dopamine, and serotonin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury | Q30470435 | ||
| The effect of testosterone upon methamphetamine neurotoxicity of the nigrostriatal dopaminergic system | Q31923560 | ||
| The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neurones | Q33256442 | ||
| Gender differences in dopaminergic function in striatum and nucleus accumbens | Q33791869 | ||
| Sex differences in motor behavior in the MPTP mouse model of Parkinson's disease | Q33835301 | ||
| Oestrogen effects on dopaminergic function in striatum | Q34018503 | ||
| Neuroprotection by estradiol. | Q34065270 | ||
| Neuroprotective effects of estrogen upon the nigrostriatal dopaminergic system | Q34292750 | ||
| Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP. | Q34361701 | ||
| Cocaine regulates MEF2 to control synaptic and behavioral plasticity | Q34818266 | ||
| Estrogen as a neuroprotectant against MPTP-induced neurotoxicity in C57/B1 mice. | Q50996925 | ||
| Risk of Parkinson disease in women: effect of reproductive characteristics. | Q51940269 | ||
| Gender differences in Parkinson's disease | Q57779630 | ||
| Gender differences in Parkinson's disease | Q64900481 | ||
| Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | Q70951248 | ||
| Distribution and steroid hormone regulation of aromatase mRNA expression in the forebrain of adult male and female rats: a cellular-level analysis using in situ hybridization | Q71512172 | ||
| The location of persistent amphetamine-induced changes in the density of dendritic spines on medium spiny neurons in the nucleus accumbens and caudate-putamen | Q73283959 | ||
| Description of Parkinson's disease as a clinical syndrome. | Q35170978 | ||
| Sex dimorphisms in the neuroprotective effects of estrogen in an animal model of Parkinson's disease. | Q35835034 | ||
| Structural plasticity associated with exposure to drugs of abuse | Q35908693 | ||
| Neuroprotective role of testosterone in the nervous system | Q35980533 | ||
| Cortical regulation of dopamine depletion-induced dendritic spine loss in striatal medium spiny neurons | Q36169973 | ||
| Gender disparities in Parkinson's disease | Q36419587 | ||
| Neuroprotective actions of sex steroids in Parkinson's disease | Q37467662 | ||
| Gonadal hormones as promoters of structural synaptic plasticity: cellular mechanisms | Q40610081 | ||
| Immunolocalization of Estrogen Receptor β in the Mouse Brain: Comparison with Estrogen Receptor α | Q40655085 | ||
| Sex differences in androgen-regulated expression of cytochrome P450 aromatase in the rat brain | Q41640228 | ||
| Exercise-induced behavioral recovery and neuroplasticity in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse basal ganglia | Q42464444 | ||
| Social odor recognition: a novel behavioral model for cognitive dysfunction in Parkinson's disease | Q43144592 | ||
| Medial nucleus of the amygdala in the adult Syrian hamster: A quantitative Golgi analysis of gonadal hormonal regulation of neuronal morphology | Q43753756 | ||
| Mouse model of Parkinsonism: a comparison between subacute MPTP and chronic MPTP/probenecid treatment | Q43759857 | ||
| Methamphetamine-gonadal steroid hormonal interactions: effects upon acute toxicity and striatal dopamine concentrations | Q43954218 | ||
| Lack of effect of testosterone and dihydrotestosterone compared to 17beta-oestradiol in 1-methyl-4-phenyl-1,2,3,6, tetrahydropyridine-mice | Q44126277 | ||
| Dose- and sex-dependent effects of the neurotoxin 6-hydroxydopamine on the nigrostriatal dopaminergic pathway of adult rats: differential actions of estrogen in males and females. | Q44283573 | ||
| Gonadal hormones affect spine synaptic density in the CA1 hippocampal subfield of male rats. | Q44357307 | ||
| Estrogen, but not testosterone, attenuates methamphetamine-evoked dopamine output from superfused striatal tissue of female and male mice | Q44385246 | ||
| Repeated estradiol treatment prevents MPTP-induced dopamine depletion in male mice | Q44453376 | ||
| Role of dopamine transporter against MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in mice | Q44488554 | ||
| Estradiol in the striatum: effects on behavior and dopamine receptors but no evidence for membrane steroid receptors | Q44552900 | ||
| Tyrosine hydroxylase and dopamine transporter expression following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of the mouse nigrostriatal pathway | Q44870587 | ||
| Estrogen attenuates the MPTP-induced loss of dopamine neurons from the mouse SNc despite a lack of estrogen receptors (ERalpha and ERbeta). | Q45142325 | ||
| Effect of reproductive factors and postmenopausal hormone use on the risk of Parkinson disease. | Q45933973 | ||
| Effects of treadmill exercise on dopaminergic transmission in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury. | Q46107271 | ||
| Testosterone enhances dopamine depletion by methamphetamine in male, but not female, mice | Q46318932 | ||
| Effects of estrogens on striatal damage after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in male and female mice | Q46405442 | ||
| Evaluation of estrogen neuroprotective effect on nigrostriatal dopaminergic neurons following 6-hydroxydopamine injection into the substantia nigra pars compacta or the medial forebrain bundle | Q46764881 | ||
| Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models. | Q46896175 | ||
| Modulatory effects of testosterone on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity. | Q48198176 | ||
| Methamphetamine-induced structural plasticity in the dorsal striatum. | Q48258372 | ||
| Sex differences in the effects of gonadectomy on amphetamine-induced rotational behavior in rats | Q48278037 | ||
| Expression of aromatase in the embryonic and postnatal mouse striatum | Q48337675 | ||
| Striatal susceptibility to a dopaminergic neurotoxin is independent of sex hormone effects on cell survival and DAT expression but is exacerbated by central aromatase inhibition. | Q48363897 | ||
| Effects of sex and androgen treatment on dendritic dimensions of neurons in the sexually dimorphic preoptic/anterior hypothalamic area of male and female ferrets | Q48430737 | ||
| A method for vibratome sectioning of Golgi-Cox stained whole rat brain | Q48494525 | ||
| Neurone specific regulation of dendritic spines in vivo by post synaptic density 95 protein (PSD-95). | Q48553849 | ||
| Estrogen decreases corpus striatal neurotoxicity in response to 6-hydroxydopamine | Q48595554 | ||
| Estrogen as a neuromodulator of MPTP-induced neurotoxicity: effects upon striatal dopamine release | Q48643724 | ||
| Neuroanatomical distribution of aromatase MRNA in the rat brain: indications of regional regulation | Q48732213 | ||
| Selective colocalization of immunoreactivity for intracellular gonadal hormone receptors and tyrosine hydroxylase in the ventral tegmental area, substantia nigra, and retrorubral fields in the rat. | Q48766437 | ||
| Effects of testosterone upon MPTP-induced neurotoxicity of the nigrostriatal dopaminergic system of C57/B1 mice | Q49011664 | ||
| Estrogen alters MPTP-induced neurotoxicity in female mice: effects on striatal dopamine concentrations and release. | Q49156412 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | striatum | Q1319792 |
| neurotoxicity | Q3338704 | ||
| toxic encephalopathy | Q7830379 | ||
| testosterone | Q27863114 | ||
| P304 | page(s) | 138471 | |
| P577 | publication date | 2011-06-08 | |
| P1433 | published in | Parkinson's disease | Q27723341 |
| P1476 | title | MPTP Neurotoxicity and Testosterone Induce Dendritic Remodeling of Striatal Medium Spiny Neurons in the C57Bl/6 Mouse | |
| P478 | volume | 2011 |
| Q50520278 | 7,8-dihydroxyflavone Ameliorates Motor Deficits Via Suppressing α-synuclein Expression and Oxidative Stress in the MPTP-induced Mouse Model of Parkinson's Disease. |
| Q42126211 | Anabolic-androgenic steroids decrease dendritic spine density in the nucleus accumbens of male rats |
| Q37185190 | Differential striatal spine pathology in Parkinson's disease and cocaine addiction: a key role of dopamine? |
| Q38785295 | Hericium erinaceus mycelium and its isolated erinacine A protection from MPTP-induced neurotoxicity through the ER stress, triggering an apoptosis cascade |
| Q38071961 | Hypogonadism and neurological diseases |
| Q51761851 | N-palmitoylethanolamide Prevents Parkinsonian Phenotypes in Aged Mice. |
| Q28482356 | Neuroprotective activities of palmitoylethanolamide in an animal model of Parkinson's disease |
| Q30400033 | Partial genetic deletion of neuregulin 1 modulates the effects of stress on sensorimotor gating, dendritic morphology, and HPA axis activity in adolescent mice |
| Q46028074 | Sex differences and hormonal modulation of ethanol-enhanced risk taking in rats. |
Search more.